Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,711 | 57,072 | 55,253 | 54,745 | 49,276 |
| Receivables | 32,136 | 29,106 | 27,731 | 26,980 | 24,278 |
| Inventories | 43,644 | 41,493 | 40,927 | 42,375 | 44,709 |
| TOTAL | $136,617 | $133,875 | $129,167 | $128,794 | $126,048 |
| Non-Current Assets | |||||
| PPE Net | 30,400 | 30,510 | 30,165 | 30,176 | 30,432 |
| Intangibles | 80,774 | 81,630 | 82,204 | 89,293 | 90,053 |
| Other Non-Current Assets | 4,160 | 3,762 | 3,607 | 3,639 | 3,522 |
| TOTAL | $115,334 | $115,902 | $115,976 | $123,108 | $124,007 |
| Total Assets | $251,951 | $249,777 | $245,143 | $251,902 | $250,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,500 | 4,500 | 4,500 | 4,500 | 4,125 |
| Accounts payable and accrued liabilities | 8,507 | 7,719 | 5,909 | 6,416 | 7,511 |
| Accrued Expenses | 4,801 | 4,536 | 3,287 | 4,082 | 5,064 |
| Other current liabilities | 2,095 | 2,095 | 2,383 | 653 | N/A |
| TOTAL | $23,474 | $22,887 | $19,979 | $19,898 | $21,044 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49,030 | 50,147 | 51,263 | 52,379 | 53,495 |
| Other Non-Current Liabilities | 3,640 | 2,703 | 2,472 | 4,092 | 4,841 |
| TOTAL | $55,599 | $57,305 | $57,615 | $61,176 | $63,279 |
| Total Liabilities | $79,073 | $80,192 | $77,594 | $81,074 | $84,323 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,308 | 42,217 | 42,203 | 42,203 | 42,202 |
| Retained earnings | 47,937 | 46,923 | 46,473 | 51,508 | 47,471 |
| Other shareholders' equity | -2,426 | -2,946 | -4,114 | -5,352 | -5,968 |
| TOTAL | $172,878 | $169,585 | $167,549 | $170,828 | $165,732 |
| Total Liabilities And Equity | $251,951 | $249,777 | $245,143 | $251,902 | $250,055 |